A Phase III, Multi-centre, Randomized Trial to Compare Rivaroxaban With Placebo for the Treatment of Symptomatic Leg Superficial Vein Thrombosis

Trial Profile

A Phase III, Multi-centre, Randomized Trial to Compare Rivaroxaban With Placebo for the Treatment of Symptomatic Leg Superficial Vein Thrombosis

Recruiting
Phase of Trial: Phase III

Latest Information Update: 09 Dec 2016

At a glance

  • Drugs Rivaroxaban (Primary)
  • Indications Venous thrombosis
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms RASET
  • Most Recent Events

    • 06 Dec 2016 Planned End Date changed from 1 Mar 2017 to 1 Mar 2018.
    • 06 Dec 2016 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017.
    • 20 Nov 2014 Status changed from not yet recruiting to recruiting, according to ClnicalTrials.gov
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top